Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02301377 · ClinicalTrials.gov registry record · NA

Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT02301377 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02301377, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

The investigators know that adherence to medications in children with cystic fibrosis (CF) is poor. Forgetfulness has often been reported as a barrier to adherence by both CF patients and their parents. Many of the investigators patients also report being motivated by the results of their lung function studies (PFTs) to stay adherent to their medications. In this study, the investigators would like to see if providing medication reminders and allowing patients to measure their lung function at home will lead to better adherence. This will be a pilot study to determine the feasibility of providing such as a device to children with CF.

Interventions

  • DEVICE Spiro PD personal spirometer

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2014-11
Est. Completion 2015-03
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02301377

The ClinicalTrials.gov registry entry for NCT02301377 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Spiro PD personal spirometer is the first listed.

NCT02301377 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02301377 about?

NCT02301377 is a clinical study titled "Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis". The investigators know that adherence to medications in children with cystic fibrosis (CF) is poor. Forgetfulness has often been reported as a barrier to adherence by both CF patients and their parents. Many of the investigators patients also report being motivated by the results of their lung funct...

What is the current status of trial NCT02301377?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2014-11. Estimated completion is 2015-03.

What interventions are being tested in trial NCT02301377?

The interventions under investigation include: Spiro PD personal spirometer (DEVICE).

Who is sponsoring clinical trial NCT02301377?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.